SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-15-000085
Filing Date
2015-03-06
Accepted
2015-03-06 16:02:00
Documents
10
Period of Report
2015-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnbt013115form10q.htm 10-Q 656187
2 EXHIBIT 31.1 gnbt013115form10qex31_1.htm EX-31.1 9437
3 EXHIBIT 31.2 gnbt013115form10qex31_2.htm EX-31.2 9419
4 EXHIBIT 32 gnbt013115form10qex32.htm EX-32 4556
  Complete submission text file 0001607062-15-000085.txt   3364476

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gnbt-20150131.xml EX-101.INS 290979
6 XBRL SCHEMA FILE gnbt-20150131.xsd EX-101.SCH 34305
7 XBRL CALCULATION FILE gnbt-20150131_cal.xml EX-101.CAL 37069
8 XBRL DEFINITION FILE gnbt-20150131_def.xml EX-101.DEF 128898
9 XBRL LABEL FILE gnbt-20150131_lab.xml EX-101.LAB 213604
10 XBRL PRESENTATION FILE gnbt-20150131_pre.xml EX-101.PRE 182138
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 15681562
SIC: 2834 Pharmaceutical Preparations